Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Cancer Science|June 1, 2022
SREBF2-STARD4 axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasisXuetian Yue, Youzi Kong, Yankun Zhang, et al.Elife|March 21, 2018
A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse modelsYuhan Zhao, Lihua Wu, Xuetian Yue, et al.Frontiers in Oncology|January 3, 2022
Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid CarcinomaJinghui Lu, Yankun Zhang, Min Sun, et al.Cancer Cell International|July 3, 2025
P4HA2 promotes the progression of papillary thyroid cancer by enhancing degradation of IκBα to activate NF-κB signaling pathwayRuowen Li, Mingjian Zhao, Min Sun, et al.Cell Cycle (Georgetown, Tex.)|April 11, 2020
Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesisXuetian Yue, Fangnan Wu, Yanchen Li, et al.Clinical and Experimental Immunology|July 22, 2024
Tim-4 alleviates acute hepatic injury by modulating homeostasis and function of NKT cellsYingchun Wang, Yuzhen Wang, Yutong Ge, et al.Oncotarget|December 5, 2014
ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YAHongxin Ma, Xuetian Yue, Lifen Gao, et al.Free Radical Biology & Medicine|May 16, 2024
TIPE1 limits virus replication by disrupting PKM2/ HIF-1α/ glycolysis feedback loopXiaolei Ren, Hui Song, Yingchun Wang, et al.Elife|August 14, 2015
BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and functionXuetian Yue, Yuhan Zhao, Juan Liu, et al.Redox Biology|May 7, 2023
Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivationYouzi Kong, Mengting Wu, Xiaoyu Wan, et al.Pageof 6